UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 256

Sortiert nach

Marginal improvement in survival among patients diagnosed with metastatic prostate cancer in the second‐line antiandrogen therapy era

Cancer medicine (Malden, MA), 2021-11, Vol.10 (22), p.7909-7920

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk of complications and urinary incontinence following cytoreductive prostatectomy： a multi-institutional study

Asian journal of andrology, 2018-01, Vol.20 (1), p.9-14

2018

Link zum Volltext

Verfügbarkeit prüfen

Risk stratification for disease progression in pT3 prostate cancer after robot-assisted radical prostatectomy

Asian journal of andrology, 2017-11, Vol.19 (6), p.700-706

2017

Link zum Volltext

Verfügbarkeit prüfen

The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer

BJU international, 2020-06, Vol.125 (6), p.792-800

2020

Link zum Volltext

Verfügbarkeit prüfen

Prostate cancer screening and management: Caution against over-interpreting the results of the latest study, ProtecT

Investigative and Clinical Urology, 2023, 64(4), , pp.310-311

Kim, Isaac Yi

2023

Link zum Volltext

Verfügbarkeit prüfen

Untargeted urine metabolite profiling by mass spectrometry aided by multivariate statistical analysis to predict prostate cancer treatment outcome

Analyst (London), 2022-06, Vol.147 (13), p.343-354

2022

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic prognosis of prostate cancer using surface‐enhanced Raman scattering of patient urine and multivariate statistical analysis

Journal of biophotonics, 2021-01, Vol.14 (1), p.e202000275-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Transcription factor 4 expression in circulating tumor cells from castration‐resistant prostate cancer

IJU case reports, 2021-05, Vol.4 (3), p.159-162

2021

Link zum Volltext

Verfügbarkeit prüfen

Refining the American Urological Association and American Society for Radiation Oncology guideline for adjuvant radiotherapy after radical prostatectomy using the pathologic Gleason score

Asian journal of andrology, 2017-01, Vol.19 (1), p.20-25

2017

Link zum Volltext

Verfügbarkeit prüfen

Abrogation of survival disparity between Black and White individuals after the USPSTF′s 2012 prostate‐specific antigen–based prostate cancer screening recommendation

Cancer, 2020-12, Vol.126 (23), p.5114-5123

2020

Link zum Volltext

Verfügbarkeit prüfen

Novel combination markers for predicting progression of nonmuscle invasive bladder cancer

International journal of cancer, 2012-08, Vol.131 (4), p.E501-E507

2012

Link zum Volltext

Verfügbarkeit prüfen

TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer

PloS one, 2019-09, Vol.14 (9), p.e0213488

2019

Link zum Volltext

Verfügbarkeit prüfen

HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: Array‐based DNA methylation and expression profiling

International journal of cancer, 2013-09, Vol.133 (5), p.1135-1142

2013

Link zum Volltext

Verfügbarkeit prüfen

Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells

Oncogene, 2004-10, Vol.23 (46), p.7651-7659

2004

Link zum Volltext

Verfügbarkeit prüfen

Dihydrotestosterone Increases Cytotoxic Activity of Macrophages on Prostate Cancer Cells via TRAIL

Endocrinology (Philadelphia), 2019-09, Vol.160 (9), p.2049-2060

2019

Link zum Volltext

Verfügbarkeit prüfen

Analysis of hOGG1 genotype as a prognostic marker for muscle invasive bladder cancer: A novel approach using peptide nucleic acid-mediated, real-time PCR clamping

Urologic oncology, 2012-09, Vol.30 (5), p.673-679

2012

Link zum Volltext

Verfügbarkeit prüfen

Global incidence of prostate cancer in developing and developed countries with changing age structures

PloS one, 2019-10, Vol.14 (10), p.e0221775-e0221775

2019

Link zum Volltext

Verfügbarkeit prüfen

Changes in prostate cancer survival among insured patients in relation to USPSTF screening recommendations

BMC urology, 2022-06, Vol.22 (1), p.91-91, Article 91

2022

Link zum Volltext

Verfügbarkeit prüfen

BMP-6 in Renal Cell Carcinoma Promotes Tumor Proliferation through IL-10―Dependent M2 Polarization of Tumor-Associated Macrophages

Cancer research (Chicago, Ill.), 2013-06, Vol.73 (12), p.3604-3614

2013

Link zum Volltext

Verfügbarkeit prüfen

Unintended consequences of decreased PSA-based prostate cancer screening

World journal of urology, 2019-03, Vol.37 (3), p.489-496

2019

Link zum Volltext

Verfügbarkeit prüfen

Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1

Cancer research (Chicago, Ill.), 2004-10, Vol.64 (20), p.7355-7360

2004

Link zum Volltext

Verfügbarkeit prüfen

RNA-seq profile of African American men with a clinically localized prostate cancer

Prostate international, 2021-09, Vol.9 (3), p.125-131

2021

Link zum Volltext

Verfügbarkeit prüfen

Association between pelvic lymph node dissection and survival among patients with prostate cancer treated with radical prostatectomy

Prostate international, 2024-06, Vol.12 (2), p.70-78

2024

Link zum Volltext

Verfügbarkeit prüfen

CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer

Frontiers in molecular biosciences, 2020-10, Vol.7, p.579874-579874

2020

Link zum Volltext

Verfügbarkeit prüfen

Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer

PloS one, 2020-01, Vol.15 (1), p.e0226219-e0226219

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 256

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(234)
Mit Volltextzugriff
(207)

Publikationsform

Sprache

Englisch
(245)
Japanisch
(18)
Koreanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Marginal improvement in survival among patients diagnosed with metastatic prostate cancer in the second‐line antiandrogen therapy era

Risk of complications and urinary incontinence following cytoreductive prostatectomy： a multi-institutional study

Risk stratification for disease progression in pT3 prostate cancer after robot-assisted radical prostatectomy

The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer

Prostate cancer screening and management: Caution against over-interpreting the results of the latest study, ProtecT

Untargeted urine metabolite profiling by mass spectrometry aided by multivariate statistical analysis to predict prostate cancer treatment outcome

Therapeutic prognosis of prostate cancer using surface‐enhanced Raman scattering of patient urine and multivariate statistical analysis

Transcription factor 4 expression in circulating tumor cells from castration‐resistant prostate cancer

Refining the American Urological Association and American Society for Radiation Oncology guideline for adjuvant radiotherapy after radical prostatectomy using the pathologic Gleason score

Abrogation of survival disparity between Black and White individuals after the USPSTF′s 2012 prostate‐specific antigen–based prostate cancer screening recommendation

Novel combination markers for predicting progression of nonmuscle invasive bladder cancer

TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer

HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: Array‐based DNA methylation and expression profiling

Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells

Dihydrotestosterone Increases Cytotoxic Activity of Macrophages on Prostate Cancer Cells via TRAIL

Analysis of hOGG1 genotype as a prognostic marker for muscle invasive bladder cancer: A novel approach using peptide nucleic acid-mediated, real-time PCR clamping

Global incidence of prostate cancer in developing and developed countries with changing age structures

Changes in prostate cancer survival among insured patients in relation to USPSTF screening recommendations

BMP-6 in Renal Cell Carcinoma Promotes Tumor Proliferation through IL-10―Dependent M2 Polarization of Tumor-Associated Macrophages

Unintended consequences of decreased PSA-based prostate cancer screening

Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1

RNA-seq profile of African American men with a clinically localized prostate cancer

Association between pelvic lymph node dissection and survival among patients with prostate cancer treated with radical prostatectomy

CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer

Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer

Suchergebnisse filtern